Graham Reeve - Aug 8, 2022 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: COO
Signature: /s/ Graham D Reeve
Stock symbol: USPH
Transactions as of: Aug 8, 2022
Transactions value $: -$352,172
Form type: 4
Date filed: 8/10/2022, 12:36 PM
Previous filing: Mar 15, 2022
Next filing: Nov 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$352K	-3.82K	-19.08%	$92.24	16.2K	Aug 8, 2022	Direct	F1, F2
holding	USPH	Common						7.94K	Aug 8, 2022	Reeve Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $92.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 16,191 shares which restrictions lapse as to 2,057 shares on October 1, 2022; 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1, and October 1, 2023; 1,418 shares on January 1, 2024; and 974 shares on each of April 1, July 1, and October 1, 2024; 974 shares on January 1, 2025; and 624 shares on April 1, July 1, October 1, 2025 with the final 640 shares lapsing on January 1, 2026 if he is still employed by the Company on those dates.

Content

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $92.50 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 16,191 shares which restrictions lapse as to 2,057 shares on October 1, 2022; 2,072 shares on January 1, 2023; 1,412 shares on each of April 1, July 1, and October 1, 2023; 1,418 shares on January 1, 2024; and 974 shares on each of April 1, July 1, and October 1, 2024; 974 shares on January 1, 2025; and 624 shares on April 1, July 1, October 1, 2025 with the final 640 shares lapsing on January 1, 2026 if he is still employed by the Company on those dates.